Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a(trifluoromethyl) benzenemethanol (E-4) is the S enantiomer of rac-5-chloro-a-(cyclopropylethynyl)-2-[[(4-methoxyphenyl)methyl]amino]-a-(trifluoromethyl)benzenemethanol (C365145). It is a chiral compound with a unique molecular structure that includes a cyclopropylacetenyl group, a trifluoromethyl group, and a 4-methoxyphenylmethylamino group.

173676-60-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (S)-5-Chloro-alpha-(cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-alpha-(trifluoromethyl)benzenemethanol

    Cas No: 173676-60-3

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier
  • Benzenemethanol,5-chloro-a-(2-cyclopropylethynyl)-2-[[(4-methoxyphenyl)methyl]amino]-a-(trifluoromethyl)-, (aS)-

    Cas No: 173676-60-3

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 173676-60-3 Structure
  • Basic information

    1. Product Name: (S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a- (trifluoromethyl) benzenemethanol (E-4)
    2. Synonyms: (S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a- (trifluoromethyl) benzenemethanol (E-4);(S)-5-Chloro-alpha-(cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-alpha-(trifluoromethyl)benzenemethanol;(S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-Methoxyphenyl)Methyl)aMino]-a- (trifluoroMethyl) benzene;(S)-5-Chloro-(cyclopropylethynyl)-2-[(4-Methoxyphenyl)Methyl]aMion trifluoroMethyl benzeneMethanol;(S)-5-Chloro-α-(cyclopropylethynyl)-2-[[(4-Methoxyphenyl)Methyl]aMino]-α-(trifluoroMethyl)benzeneMethanol;BenzeneMethanol,5-chloro-a-(2-cyclopropylethynyl)-2-[[(4-Methoxyphenyl)Methyl]aMino]-a-(trifluoroMethyl)-, (aS)-
    3. CAS NO:173676-60-3
    4. Molecular Formula: C21H19ClF3NO2
    5. Molecular Weight: 409.833
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 173676-60-3.mol
  • Chemical Properties

    1. Melting Point: 137-141ºC
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: White or light yellow crystalline powder
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: Refrigerator
    8. Solubility: Chloroform, Methanol
    9. CAS DataBase Reference: (S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a- (trifluoromethyl) benzenemethanol (E-4)(CAS DataBase Reference)
    10. NIST Chemistry Reference: (S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a- (trifluoromethyl) benzenemethanol (E-4)(173676-60-3)
    11. EPA Substance Registry System: (S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a- (trifluoromethyl) benzenemethanol (E-4)(173676-60-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 173676-60-3(Hazardous Substances Data)

173676-60-3 Usage

Uses

Used in Pharmaceutical Industry:
(S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a(trifluoromethyl) benzenemethanol (E-4) is used as an impurity in Efavirenz (E425000), an HIV-1 reverse transcriptase inhibitor. It plays a role in the synthesis and production process of Efavirenz, which is an essential medication for the treatment of HIV/AIDS.

Check Digit Verification of cas no

The CAS Registry Mumber 173676-60-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,6,7 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 173676-60:
(8*1)+(7*7)+(6*3)+(5*6)+(4*7)+(3*6)+(2*6)+(1*0)=163
163 % 10 = 3
So 173676-60-3 is a valid CAS Registry Number.

173676-60-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-5-chloro-a-(Cyclopropylacetenyl)-2-[((4-methoxyphenyl)methyl)amino]-a- (trifluoromethyl) benzenemethanol (E-4)

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:173676-60-3 SDS

173676-60-3Relevant articles and documents

In situ recycling of chiral ligand and surplus nucleophile for a noncatalytic reaction: Amplification of process throughput in the asymmetric addition step of efavirenz (DMP 266)

Choudhury, Anusuya,Moore, James R.,Pierce, Michael E.,Fortunak, Joseph M.,Valvis, Ioannis,Confalone, Pat N.

, p. 324 - 328 (2003)

The synthesis of efavirenz (DMP 266) involves a highly enantioselective asymmetric reaction of ketone 2a with lithium cyclopropylacetylide 3a in the presence of (1R,2S)-pyrrolidinylnorephedrine (PNE) 4b as the chiral mediator to produce 6b, a key advance

Highly enantioselective 1,2-addition of lithium acetylide-ephedrate complexes: Spectroscopic evidence for reaction proceeding via a 2:2 tetramer, and X-ray characterization of related complexes

Xu, Feng,Reamer, Robert A.,Tillyer, Richard,Cummins, Jordan M.,Grabowski, Edward J. J.,Reider, Paul J.,Collum, David B.,Huffman, John C.

, p. 11212 - 11218 (2000)

The key step in the manufacturing process for the HIV reverse transcriptase inhibitor efavirenz (Sustiva) involves addition of the 2:2 tetrameric complex 6 [formed from lithium cyclopropylacetylide (5) and lithium (1R,2S)-N-pyrrolidinylnorephedrate (4)] to ketone 2, to give 3 in 95% yield and 98% enantioselectivity. Studies of acetylide-alkoxide complexes in solution by NMR spectroscopy and in the solid state by X-ray crystallography are described. Studies of the asymmetric addition reaction involving 2:2 tetramer 6 using low-temperature NMR spectroscopy provide conclusive evidence for formation of 2:1:1 tetramer 9 containing the product alkoxide 3. Observation of this reaction intermediate strongly supports the proposed reaction mechanism involving the tetramer 6 in the stereo-determining step.

Enantioselective alkynylation of a prochiral ketone catalyzed by C2-symmetric diamino diols

Jiang, Biao,Feng, Yan

, p. 2975 - 2977 (2007/10/03)

C2-Symmetric diamino diols were used as chiral ligands to induce the asymmetric addition of lithium acetylides to carbonyl groups. The enantiomeric excesses (up to 99% ee) depended on the structure of the acetylene.

Practical asymmetric synthesis of Efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor

Pierce, Michael E.,Parsons Jr., Rodney L.,Radesca, Lilian A.,Lo, Young S.,Silverman, Stuart,Moore, James R.,Islam, Qamrul,Choudhury, Anusuya,Fortunak, Joseph M. D.,Nguyen, Dieu,Luo, Chi,Morgan, Susan J.,Davis, Wayne P.,Confalone, Pat N.,Chen, Cheng-Yi,Tillyer, Richard D.,Frey, Lisa,Tan, Lushi,Xu, Feng,Zhao, Dalian,Thompson, Andrew S.,Corley, Edward G.,Grabowski, Edward J. J.,Reamer, Robert,Reider, Paul J.

, p. 8536 - 8543 (2007/10/03)

A highly enantioselective and practical synthesis of the HIV-1 reverse transcriptase inhibitor efavirenz (1) is described. The synthesis proceeds in 62% overall yield in seven steps from 4-chloroaniline (6) to give efavirenz (1) in excellent chemical and optical purity. A novel, enantioselective addition of Li-cyclopropyl acetylide (4a) to p-methoxybenzyl-protected ketoaniline 3a mediated by (1R,2S)-N-pyrrolidinylnorephedrine lithium alkoxide (5a) establishes the stereogenic center in the target with a remarkable level of stereocontrol.

Use of an Ephedrine Alkoxide to Mediate Enantioselective Addition of an Acetylide to a Prochiral Ketone: Asymmetric Synthesis of the Reverse Transcriptase Inhibitor L-743,726.

Thompson, Andrew S.,Corley, Edward G.,Huntington, Martha F.,Grabowski, E. J. J.

, p. 8937 - 8940 (2007/10/02)

The asymmetric synthesis of L-743,726 was achieved in six steps with an overall yield of 31 percent.The asymmetry was introduced using a lithiated ephedrine to mediate acetylide addition to a trifluoromethyl ketone with an enantiomeric excess of 96-98 percent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 173676-60-3
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-0571-87562588,87562578,87562573 Our Legal adviser: Lawyer